Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to Valeant and Kadmon Ink Two Deals Totaling $12.5M Up Front for Chronic HCV Drugs

  • Page 1 of 1 (4 items) 1 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »